SunEdison Inc. (NYSE:SUNE) reported a second quarter loss of $0.93 per share Thursday morning, compared to the loss of $0.16 per share last year. Analysts expected a loss of $0.55 per share. SunEdison, Inc. (NYSE:SUNE) belongs to Technology sector. Its net profit margin is -41.60% and weekly performance is -33.36%. On last trading day company shares ended up $17.08. SunEdison, Inc. (NYSE:SUNE) distance from 50-day simple moving average (SMA50) is -41.71%.
Genworth Financial Inc. (NYSE:GNW) confirmed Wednesday that it reduced about 220 positions in the first six months of this year as the Henrico County-based insurer looks to cut costs. Genworth Financial, Inc. (NYSE:GNW) shares moved down -7.61% in last trading session and ended the day at $5.22. GNW return on assets is -1.10%. Genworth Financial, Inc. (NYSE:GNW) quarterly performance is -36.73%.
Keurig Green Mountain (NASDAQ: GMCR) reported Q3 EPS of $0.80, $0.01 better than the analyst estimate of $0.79. Revenue for the quarter came in at $970 billion versus the consensus estimate of $1.04 billion. Sees Q4 Non-GAAP EPS in a range of $0.70 to $0.75, versus the consensus of $0.97.On 06 August, Keurig Green Mountain, Inc. (NASDAQ:GMCR) shares moved down -29.75% and was closed at $52.67. GMCR EPS growth in last 5 year was 52.70%. Keurig Green Mountain, Inc. (NASDAQ:GMCR) year to date (YTD) performance is -59.89%.
Fitbit Inc. (NYSE:FIT) posted a $131.8 million profit in 2014, compared with a loss of $51.6 million a year earlier. Meanwhile, sales surged to $745.4 million in 2014 from $271.1 million a year earlier. In the latest period, Fitbit said it sold 4.5 million tracking devices with the average selling price rising to $88 from $63 a year earlier, company officials said Wednesday in a conference call with analysts. Fitbit Inc. (NYSE:FIT) ended the last trading day at $44.60. Company weekly volatility is calculated as 6.71% and price to cash ratio as 38.66. Fitbit Inc. (NYSE:FIT) showed a weekly performance of -1.31%.
Opko Health, Inc. (NYSE:OPK) reported Consolidated revenues increased to $42.4 and $72.5 million during the three and six months ended June 30, 2015 from $23.5 and $45.8 million in the comparable periods of 2014. Revenue for the three and six months ended June 30, 2015 included $17.7 and $30.2 million of revenue resulting from OPKO’s collaboration agreement with Pfizer. Opko Health, Inc. (NYSE:OPK) shares moved down -13.72% in last trading session and ended the day at $13.90. OPK Gross Margin is 53.60% and its return on assets is -18.10%. Opko Health, Inc. (NYSE:OPK) quarterly performance is -1.70%.